Search results for “Egfr signaling” companies
Free sign up to view the full data
Key Players
Order by:
Innovation Intensity
With the analysis among 82 patents, we discovered top 17 key players by total patent application. Janssen Biotech, Exelixis, Inc., BenevolentAI Bio Ltd. are dominant in this area. They take 45.12% of the total patent filing.
Janssen Biotech
Belgium
Patent: 25
Exelixis, Inc.
California, United States
Patent: 6
BenevolentAI Bio Ltd.
United Kingdom
Patent: 6
Antisoma Research Ltd.
United Kingdom
Patent: 5
Cell Signaling Technology, Inc.
Massachusetts, United States
Patent: 4
Shanghai EpimAb Biotherapeutics Co. Ltd.
Shanghai Shi, China
Patent: 4
ImmunoGen, Inc.
Massachusetts, United States
Patent: 3
Sarossa Capital Ltd.
United Kingdom
Patent: 3
PamGene BV
Noord-Brabant, Netherlands
Patent: 3
Rikshospitalet-Radiumhospitalet hHF
Norway
Patent: 3
Startups & Unicorns
Order by:
Innovation Intensity
With the analysis among 6 patents, we discovered top 1 start-ups by total patent application.
BenevolentAI Bio Ltd.
United Kingdom
Patent: 6
Fast-Growing
Order by:
Innovation in recent 5 years
With the analysis among related 22 patents applied in the last 5 years. We discover 6 most active companies in this area. The fast-growing Shanghai EpimAb Biotherapeutics Co. Ltd., Janssen Biotech, St. Jude Children's Research Hospital, Inc. take 40.91% of patent filing during this period.
Shanghai EpimAb Biotherapeutics Co. Ltd.
Shanghai Shi, China
Patent: 4
Janssen Biotech
Belgium
Patent: 3
St. Jude Children's Research Hospital, Inc.
Tennessee, United States
Patent: 2
The Hong Kong University of Science & Technology
Hong Kong SAR, China
Patent: 1
Guangzhou Qizhuang Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 1
U.S. Department of Veteran Affairs
District of Columbia, United States
Patent: 1
New Entrants
Order by:
Innovation in recent 5 years
With the analysis among related 22 patents in last 5 years, we discover 4 new entrants. Shanghai EpimAb Biotherapeutics Co. Ltd., St. Jude Children's Research Hospital, Inc., The Hong Kong University of Science & Technology are the most active new entrants in this area.
Shanghai EpimAb Biotherapeutics Co. Ltd.
Shanghai Shi, China
Patent: 4
St. Jude Children's Research Hospital, Inc.
Tennessee, United States
Patent: 2
The Hong Kong University of Science & Technology
Hong Kong SAR, China
Patent: 1
Guangzhou Qizhuang Biotechnology Co., Ltd.
Guangdong Sheng, China
Patent: 1
Research Institutions
Order by:
Innovation Intensity
With the analysis among 12 patents, we discovered top 5 universities and scientific research institutions by total patent application. Massachusetts Institute of Technology, The Hong Kong University of Science & Technology, National Taiwan University are dominant in this area. They take 50.00% of the total patent filing.
Massachusetts Institute of Technology
Massachusetts, United States
Patent: 2
The Hong Kong University of Science & Technology
Hong Kong SAR, China
Patent: 1
National Taiwan University
Taiwan Province, China
Patent: 1
President & Fellows of Harvard College
Massachusetts, United States
Patent: 1
Okayama University
Okayama-ken, Japan
Patent: 1
Keywords Quick Entry
Popular
Physics
Chemistry
Engineering
Materials science
Computer science
Biology
Medicine
MetalElectrodeVoltageSemiconductorPolymerElectricityCoatingFiberDisplay deviceRaw materialElectric motorUltimate tensile strengthNozzleCarbonBuilding constructionAlkylService lifeElectronOxideOxygenSolventControl unitFlangeControl systemDrugLight sourcePistonDiseaseElectric powerHigh pressure
View more
Page generation time: